Richard Pzena's position in Bristol-Myers Squibb is currently worth $693M. That's 2.19% of their equity portfolio (18th largest holding). The first Bristol-Myers Squibb trade was made in Q3 2019. Since then Richard Pzena bought shares twelve more times and sold shares on eleven occasions. The investor's estimated purchase price is $798M, resulting in a loss of 13%.